Gonadorelin acetate is the acetate salt of synthetic native gonadotropin-releasing hormone (GnRH, also called LH-RH), a ten-amino-acid neuropeptide that stimulates pituitary gonadotrope release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) when delivered in a pulsatile laboratory or clinical-protocol setting; as a catalog research reagent it supports receptor assays, endocrine-modeling work and analog structure-activity comparisons (USP Gonadorelin Acetate monograph). This guide covers sequence identity, salt-form documentation, the pulse-versus-continuous biology that defines the molecule’s pharmacology, and QC expectations. It provides no human dosing schedule; catalog material is research-use only.
Chemical identity and salt form
Native GnRH is a small decapeptide with a cyclized N-terminal pyroglutamate (5-oxoproline) and an amidated C-terminal glycine:
- Sequence: 5-oxoPro-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 (XHWSYGLRPG shorthand in chemical records)
- Free peptide CAS: 33515-09-2; gonadorelin acetate salt: CAS 78308-49-3 per USP records (USP monograph; FDA PrecisionFDA GONADORELIN record; PubChem diacetate record CID 53396033).
The acetate salt contributes counterion mass, so a CoA should state whether a reported mg quantity refers to free peptide or acetate salt; this distinction changes molar calculations and should not be guessed from the product name.
Why pulse pattern matters biologically
A defining feature of GnRH biology is that the same molecule behaves differently according to delivery pattern. Endogenous GnRH neurons secrete the peptide in pulses; pulsatile receptor stimulation supports normal gonadotrope function, whereas continuous receptor occupancy leads to receptor desensitization and a paradoxical fall in LH and FSH output (Hammond & Ory, Arch Intern Med 1985). Native GnRH itself has a short biological half-life because hypothalamic and pituitary endopeptidases cleave the molecule at the Gly-Leu bond and near the C-terminus; this rapid clearance is why synthetic long-acting analogs were developed by modifying those cleavage sites.
For a laboratory program, the practical implications are:
- Assays comparing native gonadorelin with modified analogs must hold delivery mode and timing constant.
- Desensitization experiments require sustained-exposure controls and time-course sampling rather than a single endpoint.
- Half-life and degradation studies use proteolysis incubations with LC-MS or immunoassay readouts.
Research applications
Typical nonclinical uses include:
1. GnRH receptor pharmacology: receptor-binding and calcium/cAMP signaling assays using native peptide as the reference agonist.
2. Axis modeling: studies placing upstream neuropeptides (such as kisspeptin research peptide) above GnRH and downstream gonadotropin/glycoprotein hormones such as HCG research material in pathway diagrams and assay panels.
3. Analog development: structure-activity comparisons among native peptide, agonists and antagonists; modifications at position 6 and the C-terminus are the classic design spaces.
4. Analytical method development: quantification of a small amidated decapeptide in buffer or serum matrices, including salt-form verification.
Documentation and QC checklist
Because gonadorelin has no dedicated catalog product page on this store, researchers evaluating external lots should request:
- Sequence confirmation and intact mass consistent with the decapeptide reference record.
- Explicit salt form (acetate versus free peptide) and content basis.
- HPLC purity with method details, related peptides and any residual acetate/solvent data.
- Lot number, manufacture date, retest condition and storage statement matching vial labels.
- Solubility guidance and stability notes for the planned assay buffer.
Sealed lyophilized powder should be kept dry and cool; prepared solutions should be aliquoted and validated for stability rather than assigned a generic shelf life.
Compliance boundary
Gonadorelin acetate appears in regulated clinical products used under prescription oversight; catalog research material here is not a substitute for those labeled products. This guide does not recommend administration for fertility, endocrine therapy or any personal use. Researchers must follow institutional review, chemical safety and applicable procurement regulations, including any licensing rules that apply to endocrine-active peptide reagents.
Frequently Asked Questions
What is gonadorelin acetate?
It is the acetate salt of synthetic native GnRH, a 10-residue amidated neuropeptide that stimulates pituitary LH and FSH release when applied in pulsatile research settings.
What is the native GnRH sequence?
5-oxoPro-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2; the free peptide and acetate salt carry different CAS registry numbers and different mass bases.
Why does delivery pattern matter?
Pulsatile exposure supports receptor responsiveness, while continuous occupancy causes desensitization and reduced gonadotropin output; assay design must therefore control delivery mode.
What is the difference from GnRH analogs?
Native gonadorelin is rapidly cleaved by peptidases; analogs such as triptorelin substitute residues like D-Trp at position 6 to resist degradation and extend action.
What research uses suit this reagent?
Receptor pharmacology, axis-modeling assays, analog structure-activity comparisons and analytical quantification methods for a small amidated peptide.
What should the CoA contain?
Sequence/mass identity, salt-form statement, HPLC purity with methods, content basis, related-peptide data and lot traceability.
Is this a clinical treatment product?
No. Catalog material is research-only; regulated clinical products are separate prescription formulations with their own labeling and oversight.
Related research catalog: HCG research material · Kisspeptin research peptide · lyophilized research reagents with lot documentation on request · laboratory research only; not for human or veterinary administration.
Related Research Guides
- triptorelin acetate structure and assay notes
- hCG research: glycoprotein structure and potency QC
- AICAR research: AMPK activation and assay controls
